Clinical Trials Directory

Trials / Completed

CompletedNCT06484140

Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Evaluation of the Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Fudan University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are: * Does the intervention alleviate participants' financial toxicity? * Does the intervention enhance participants' cost-related health literacy? * Does the intervention improve participants' shared decision-making? * Does the intervention reduce participants' perceived stress? Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness. Participants will receive the comprehensive financial navigation, including: * Needs assessment; * Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and service referral; * Personalized counseling.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFinancial NavigationDuring hospitalization, participants will receive needs assessment, and one-on-one cost-related health education with a material booklet. Resource and service referral will be delivered face-to-face or by phone when the navigator identifies unaddressed problems. Within three months after discharge, participants will receive monthly follow-up phone calls and personalized counseling via WeChat.
OTHERUsual CareParticipants will receive usual oncology care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support.

Timeline

Start date
2024-06-17
Primary completion
2024-11-11
Completion
2024-11-17
First posted
2024-07-03
Last updated
2025-02-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06484140. Inclusion in this directory is not an endorsement.